查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529772

半固態藥物契約製造市場規模、佔有率、趨勢分析報告：按類型、產品、最終用途、公司規模、地區、細分市場預測，2024-2030年

Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Topical, Transdermal, Oral), By Product (Creams, Gels), By End Use, By Company Size, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

市場規模及趨勢

預計2023年全球半固態藥品契約製造市場規模為175.7億美元，預計2024年至2030年複合年成長率為11.12%。對患者友善藥物的需求不斷成長，加上皮膚病、關節炎和疼痛管理等慢性疾病的盛行率不斷上升，正在推動市場成長。此外，由於其成本效益，對製造外包的需求正在增加。此外，監管合規性和品質保證、技術進步（包括配方技術創新）可能會在預測期內推動需求。

皮膚病、關節炎等慢性病的高盛行率以及由於世界老化而對疼痛管理解決方案的需求是市場成長的主要驅動力。根據世界衛生組織 (WHO) 統計，估計有 18 億人在任何特定時間都患有 3,000 多種皮膚病，對有效治療的需求龐大。美國人口正在快速老化。根據人口研究所2024年1月發布的情況說明書，65歲及以上的美國人數量將從2022年的5800萬躍升至2050年的8200萬，大幅成長47%。此外，65歲及以上人口占總人口的比例預計將從17%上升至23%，成為美國歷史上最古老的年齡分佈。

此外，根據2021年全球疾病負擔研究，皮膚病在全球健康負擔中排名第8。固態製劑，例如乳霜劑和軟膏，是許多皮膚狀況的首選給藥方法，並且塗布、溫和。隨著製藥公司尋求具有專業知識的合作夥伴來高效、大量生產這些藥物，對皮膚病和疼痛管理治療的需求激增正在推動市場成長。此外，根據 CDC 2019 年至 2021 年期間的報告，關節炎是美國最常見的疾病，影響 17.9% 的男性和 24.2% 的女性 (NHIS)。

此外，契約製造允許製藥公司利用製造能力，遵守監管標準，並獲得支援以最大限度地降低與內部製造設施相關的成本。製藥公司和契約製造製造商之間的策略聯盟有助於高效生產半固態製劑，促進快速進入市場和最佳化現有製劑。建立和維護半固態製劑的內部生產線需要大量投資。這包括混合、填充和包裝這些劑型的專用設備，以及有效操作它們的專業知識。透過與契約製造製造商 (CMO) 合作，製藥公司可以避免這些前期成本和持續的維護成本。 CMO 專注於半固態藥品的製造，並具有規模經濟，使他們能夠利用其專業知識和設備為多個客戶服務。

由於配方技術的進步和對以患者為中心的解決方案日益濃厚的興趣，半固態配方的契約製造市場正在經歷創新發展的激增。配方創新包括使用奈米和微粉化顆粒來提高生物有效性，以及使用先進的粒度分佈技術來最佳化穩定性和性能。製藥公司也優先考慮患者的依從性，並引入易於使用的包裝設計和自我管理功能。製藥公司和契約製造製造商之間的策略聯盟能夠實現這些特種配方的高效生產和快速市場進入。

儘管市場主要是由對藥用霜劑、軟膏和凝膠的需求不斷成長推動的，但 CMO 也可以利用他們在這些半固態配方方面的專業知識來滿足化妝品行業的需求。這使您能夠擴大基本客群並最佳化您的生產線。此外，消費者對外用護膚品的興趣日益濃厚，為 CMO 與化妝品公司合作開發和製造創新乳霜、精華液和乳液創造了更多機會。製藥和化妝品領域之間的這種協同效應正在推動整體市場的成長。

此外，對個人化醫療的需求正在刺激針對個人需求的客製化固態劑型的開發。吸收增強成分和新型賦形劑也被用來提高這些局部治療的功效和生物有效性。這些多方面的創新正在改變半固態藥物市場，為各種皮膚、眼睛和慢性疼痛病症提供更有效、更方便和個人化的解決方案。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 半固態藥物契約製造市場的變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 半固態藥物契約製造市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章半固態藥品契約製造市場：按類型估計和趨勢分析

  • 市場佔有率：依類型分類，2023/2030
  • 細分儀表板
  • 全球半固態藥物契約製造市場前景：按類型
  • 2018-2030年市場規模及預測及趨勢分析
  • 局部的
  • 經皮的
  • 口服

第5章 半固態藥物契約製造市場：依產品估價及趨勢分析

  • 市場佔有率：依產品分類，2023/2030
  • 細分儀表板
  • 全球半固態藥物契約製造市場展望：依產品分類
  • 2018-2030年市場規模及預測及趨勢分析
  • 奶油
  • 軟膏
  • 凝膠
  • 洗劑
  • 貼上
  • 其他

第6章 半固態藥物契約製造市場：依最終用途分類的估計與趨勢分析

  • 市場佔有率：最終用途，2023/2030
  • 細分儀表板
  • 全球半固態藥品契約製造市場展望：依最終用途分類
  • 2018-2030年市場規模及預測及趨勢分析
  • 製藥公司
  • 化妝品公司
  • 其他

第7章 半固態藥物契約製造市場：依公司規模估算與趨勢分析

  • 市場佔有率：依公司規模分類，2023/2030
  • 細分儀表板
  • 全球半固態藥品契約製造市場前景：依公司規模分類
  • 2018-2030年市場規模及預測及趨勢分析
  • 大型企業
  • 中型企業/中小企業
  • 其他

第8章 半固態藥品契約製造市場：區域估計和趨勢分析

  • 市場佔有率分析：按地區分類，2023 年和 2030 年
  • 市場儀表板：按地區
  • 2018-2030年市場規模及預測及趨勢分析：
  • 北美洲
    • 2018-2030 年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030 年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東和非洲市場估計和預測：2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
  • 公司簡介
    • Lonza Group Ltd.
    • Lubrizol Life Science
    • Cambrex Corporation
    • Contract Pharmaceuticals Limited
    • Bora Pharmaceutical CDMO
    • Ascendia Pharmaceuticals
    • Pierre Fabre group
    • Piramal Pharma Solutions
    • DPT Laboratories, LTD
    • MedPharm Ltd
    • Catalent, Inc.
    • Recipharm AB
    • Aenova Group
    • Almac Group
    • Ajinomoto Bio-Pharma Services
Product Code: GVR-4-68040-345-3

Market Size & Trends

The global semi-solid dosage contract manufacturing market size was valued at USD 17.57 billion in 2023 and is projected to grow at a CAGR of 11.12% from 2024 to 2030. The rising demand for patient-friendly medications coupled with growing prevalence of chronic diseases such as skin diseases, arthritis, and pain management aids the market growth. Moreover, there is a growing demand for manufacturing outsourcing due to its cost-effectiveness. Furthermore, regulatory compliance and quality assurance, technological advancements including innovation in formulation technologies, are likely to boost their demand over the forecast period.

The high prevalence of chronic conditions such as skin diseases, arthritis and the requirement for pain management solutions due to the ageing population around the world is a major factor for the market growth. With an estimated 1.8 billion people affected by over 3,000 types of skin conditions at any given time, according to the World Health Organization, there's a massive demand for effective treatments. The U.S. population is experiencing a significant shift towards aging. According to the January 2024 fact sheet by the Population Reference Bureau, the number of Americans aged 65 and older is expected to surge from 58 million in 2022 to 82 million by 2050, representing a substantial 47% increase. Additionally, the proportion of the total population comprised of individuals aged 65 and older is projected to rise from 17% to 23%, marking the oldest age distribution in U.S. history.

In addition, according to the Global Burden of Disease Study 2021, skin diseases rank as the eighth leading cause of global health burden. Semi-solid dosage forms, such as creams and ointments, are a preferred method of administration for many skin diseases, offering a convenient and mess-free application. This surge in demand for skin condition and pain management treatments is propelling the growth of the market, as pharmaceutical companies seek out partners with the expertise to produce these medications efficiently and in large quantities. Further, according to the CDC report covering the period from 2019 to 2021, arthritis was most prevalent in 17.9% of men and 24.2% of women in the U.S. (NHIS).

Additionally, contract manufacturing enables pharmaceutical companies to access manufacturing capabilities, adhere to regulatory standards, and support to minimize costs associated with in-house production facilities. Strategic collaborations between pharmaceutical companies and contract manufacturers are instrumental in the efficient production of semi solid dosage forms, facilitating faster market entry for drugs further optimization of existing formulations. Setting up and maintaining in-house production lines for semi-solid medications requires substantial investments. This includes specialized equipment for mixing, filling, and packaging these dosage forms, as well as the expertise to operate them efficiently. By partnering with a contract manufacturer (CMO), pharmaceutical companies can bypass these upfront costs and ongoing maintenance expenses. CMOs specialize in semi-solid production and have economies of scale, allowing them to leverage their expertise and equipment for multiple clients.

The semi-solid dosage contract manufacturing market is witnessing a surge of innovative developments, driven by advancements in formulation technology and a growing focus on patient-centric solutions. Formulation innovations include the use of nano and micronized particles to enhance bioavailability, as well as sophisticated particle size distribution techniques to optimize stability and performance. Manufacturers are also prioritizing patient compliance, with the introduction of user-friendly packaging designs and self-administration features. Strategic collaborations between pharmaceutical companies and contract manufacturers are enabling efficient production and faster market entry of these specialized formulations.

While the market is primarily driven by the growing demand for pharmaceutical creams, ointments, and gels, CMOs can leverage their expertise in these semi-solid dosage forms to cater to the cosmetics industry as well. This allows them to expand their client base and optimize production lines. Furthermore, the growing consumer interest in topical skincare products creates additional opportunities for CMOs to partner with cosmetic companies in developing and manufacturing innovative creams, serums, and lotions. This synergy between the pharmaceutical and cosmetic sector helps to fuel the overall growth of the market.

Furthermore, the demand for personalized medicine is fueling the development of customized semi-solid dosage forms tailored to individual needs. Absorption-enhancing ingredients and novel excipients are also being leveraged to improve the efficacy and bioavailability of these topical treatments. These multifaceted innovations are transforming the semi-solid dosage form market, offering more effective, convenient, and personalized solutions for a wide range of skin, eye, and chronic pain conditions.

Global Semi-solid Dosage Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global semi-solid dosage contract manufacturing market report on the basis of type, product, end use, company size and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Topical
  • Transdermal
  • Oral
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Creams
  • Ointments
  • Gels
  • Lotions
  • Pastes
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical Companies
  • Cosmeceutical Companies
  • Others
  • Company Size Outlook (Revenue, USD Million, 2018 - 2030)
  • Large Size Companies
  • Medium & Small Size Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Product
    • 1.2.3. End Use
    • 1.2.4. Company Size
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Semi-solid Dosage Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for patient-friendly medications
      • 3.2.1.2. Growing prevalence of chronic diseases
      • 3.2.1.3. Growing demand of manufacturing outsourcing
      • 3.2.1.4. Regulatory Compliance
      • 3.2.1.5. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Quality control challenges
  • 3.3. Semi-solid Dosage Contract Manufacturing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Semi-solid Dosage Contract Manufacturing Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Semi-solid Dosage Contract Manufacturing Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Topical
    • 4.5.1. Topical market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Transdermal
    • 4.6.1. Transdermal market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Oral
    • 4.7.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Semi-solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis

  • 5.1. Product Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Semi-solid Dosage Contract Manufacturing Market by Product Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Creams
    • 5.5.1. Creams market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Ointments
    • 5.6.1. Ointments market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Gels
    • 5.7.1. Gels market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Lotions
    • 5.8.1. Lotions market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Pastes
    • 5.9.1. Pastes market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Other
    • 5.10.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Semi-solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Semi-solid Dosage Contract Manufacturing Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Pharmaceutical companies
    • 6.5.1. Pharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Cosmeceutical companies
    • 6.6.1. Cosmeceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Other
    • 6.7.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Semi-solid Dosage Contract Manufacturing Market: Company Size Estimates & Trend Analysis

  • 7.1. Company Size Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Semi-solid Dosage Contract Manufacturing Market by Company Size Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Large Size Companies
    • 7.5.1. Large size companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Medium & Small Size Companies
    • 7.6.1. Medium & small size companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Semi-solid Dosage Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory Scenario
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory Scenario
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory Scenario
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory Scenario
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory Scenario
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory Scenario
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory Scenario
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory Scenario
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory Scenario
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory Scenario
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory Scenario
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory Scenario
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory Scenario
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory Scenario
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory Scenario
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Regulatory framework
      • 8.8.5.3. Competitive scenario
      • 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
  • 9.4. Company Profiles
    • 9.4.1. Lonza Group Ltd.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Others benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Lubrizol Life Science
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Others benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Cambrex Corporation
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Others benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Contract Pharmaceuticals Limited
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Others benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Bora Pharmaceutical CDMO
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Others benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Ascendia Pharmaceuticals
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Others benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Pierre Fabre group
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Others benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Piramal Pharma Solutions
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Others benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. DPT Laboratories, LTD
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Others benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. MedPharm Ltd
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Others benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Catalent, Inc.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Others benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Recipharm AB
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Others benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Aenova Group
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Others benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Almac Group
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Others benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Ajinomoto Bio-Pharma Services
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Others benchmarking
      • 9.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 7 U.S. semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 11 Canada semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 15 Mexico semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 16 Mexico semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Mexico semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 19 Europe semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Europe semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 24 Germany semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 28 UK semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 29 UK semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 UK semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 32 France semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 33 France semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 34 France semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 France semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 36 Italy semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 37 Italy semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Italy semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 40 Spain semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 41 Spain semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Spain semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 44 Denmark semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Denmark semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Denmark semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 48 Sweden semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 49 Sweden semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Sweden semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 52 Norway semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 53 Norway semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 54 Norway semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Norway semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 61 China semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 62 China semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 63 China semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 64 China semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 65 Japan semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 66 Japan semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Japan semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 69 India semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 70 India semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 71 India semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 72 India semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 73 South Korea semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 74 South Korea semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 75 South Korea semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 76 South Korea semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 77 Australia semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 78 Australia semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Australia semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 81 Thailand semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 82 Thailand semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 84 Thailand semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 85 Latin America semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 86 Latin America semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 87 Latin America semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Latin America semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 89 Brazil semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 90 Brazil semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 91 Brazil semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Brazil semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 93 Argentina semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 94 Argentina semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 95 Argentina semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 96 Argentina semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 97 MEA semi-solid dosage contract manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 98 MEA semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 99 MEA semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 100 MEA semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 101 MEA semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 102 South Africa semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 103 South Africa semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 104 South Africa semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 105 South Africa semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 110 UAE semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 111 UAE semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 112 UAE semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 113 UAE semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)
  • Table 114 Kuwait semi-solid dosage contract manufacturing market, by type, 2018 - 2030 (USD Million)
  • Table 115 Kuwait semi-solid dosage contract manufacturing market, by product, 2018 - 2030 (USD Million)
  • Table 116 Kuwait semi-solid dosage contract manufacturing market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Kuwait semi-solid dosage contract manufacturing market, by company size, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Semi-solid dosage contract manufacturing market: market outlook
  • Fig. 14 Semi-solid dosage contract manufacturing competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Semi-solid dosage contract manufacturing market driver impact
  • Fig. 20 Semi-solid dosage contract manufacturing market restraint impact
  • Fig. 21 Semi-solid dosage contract manufacturing market strategic initiatives analysis
  • Fig. 22 Semi-solid dosage contract manufacturing market: Type movement analysis
  • Fig. 23 Semi-solid dosage contract manufacturing market: Type outlook and key takeaways
  • Fig. 24 Topical market estimates and forecast, 2018 - 2030
  • Fig. 25 Transdermal market estimates and forecast, 2018 - 2030
  • Fig. 26 Oral market estimates and forecast, 2018 - 2030
  • Fig. 27 Semi-solid dosage contract manufacturing Market: Product movement analysis
  • Fig. 28 Semi-solid dosage contract manufacturing market: Product outlook and key takeaways
  • Fig. 29 Creams market estimates and forecasts, 2018 - 2030
  • Fig. 30 Immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 31 Ointments market estimates and forecasts, 2018 - 2030
  • Fig. 32 Gels market estimates and forecasts, 2018 - 2030
  • Fig. 33 Lotions market estimates and forecasts, 2018 - 2030
  • Fig. 34 Pastes market estimates and forecasts, 2018 - 2030
  • Fig. 35 Others market estimates and forecast, 2018 - 2030
  • Fig. 36 Semi-solid dosage contract manufacturing market: End Use movement analysis
  • Fig. 37 Semi-solid dosage contract manufacturing market: End Use outlook and key takeaways
  • Fig. 38 Pharmaceutical companies market estimates and forecast, 2018 - 2030
  • Fig. 39 Cosmeceutical companies market estimates and forecast, 2018 - 2030
  • Fig. 40 Others market estimates and forecast, 2018 - 2030
  • Fig. 41 Semi-solid dosage contract manufacturing market: End use movement analysis
  • Fig. 42 Semi-solid dosage contract manufacturing market: End use outlook and key takeaways
  • Fig. 43 Large size companies market estimates and forecasts, 2018 - 2030
  • Fig. 44 Medium & small size companies market estimates and forecasts, 2018 - 2030
  • Fig. 45 Others market estimates and forecasts, 2018 - 2030
  • Fig. 46 Global semi-solid dosage contract manufacturing market: Regional movement analysis
  • Fig. 47 Global semi-solid dosage contract manufacturing market: Regional outlook and key takeaways
  • Fig. 48 Global semi-solid dosage contract manufacturing market share and leading players
  • Fig. 49 North America market share and leading players
  • Fig. 50 Europe market share and leading players
  • Fig. 51 Asia Pacific market share and leading players
  • Fig. 52 Latin America market share and leading players
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 North America, by country
  • Fig. 55 North America
  • Fig. 56 North America market estimates and forecasts, 2018 - 2030
  • Fig. 57 U.S. key country dynamics
  • Fig. 58 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 59 Canada key country dynamics
  • Fig. 60 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 61 Mexico key country dynamics
  • Fig. 62 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 63 Europe
  • Fig. 64 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 65 UK key country dynamics
  • Fig. 66 UK market estimates and forecasts, 2018 - 2030
  • Fig. 67 Germany key country dynamics
  • Fig. 68 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 69 France key country dynamics
  • Fig. 70 France market estimates and forecasts, 2018 - 2030
  • Fig. 71 Italy key country dynamics
  • Fig. 72 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 73 Spain key country dynamics
  • Fig. 74 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 75 Denmark key country dynamics
  • Fig. 76 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 77 Sweden key country dynamics
  • Fig. 78 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 79 Norway key country dynamics
  • Fig. 80 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 81 Asia Pacific
  • Fig. 82 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 83 China key country dynamics
  • Fig. 84 China market estimates and forecasts, 2018 - 2030
  • Fig. 85 Japan key country dynamics
  • Fig. 86 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 87 India key country dynamics
  • Fig. 88 India market estimates and forecasts, 2018 - 2030
  • Fig. 89 Thailand key country dynamics
  • Fig. 90 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 91 South Korea key country dynamics
  • Fig. 92 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 93 Australia key country dynamics
  • Fig. 94 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 95 Latin America
  • Fig. 96 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 97 Brazil key country dynamics
  • Fig. 98 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 99 Argentina key country dynamics
  • Fig. 100 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 101 Middle East and Africa
  • Fig. 102 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 103 South Africa key country dynamics
  • Fig. 104 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 105 Saudi Arabia key country dynamics
  • Fig. 106 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 107 UAE key country dynamics
  • Fig. 108 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 109 Kuwait key country dynamics
  • Fig. 110 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 111 Market share of key market players- Semi-solid dosage contract manufacturing market